[Abstract] Activation of type 1 cannabinoid (CB1) receptors by endogenous, exogenous (cannabis derivatives) or synthetic cannabinoids (i.e., CP 55.940, Win-2) has a wide variety of behavioral effects due to the presence of CB1 receptors in the brain. In situ hybridization and immunohistochemical techniques have been crucial for defining the CB1 receptor expression and localization at the cellular level. Nevertheless, more advanced methods are needed to reveal the precise topography of CB1 receptors in the brain, especially in unsuspected sites such as other cell types and organelles with low receptor expression (e.g., glutamatergic neurons, astrocytes, mitochondria). High-resolution immunoelectron microscopy provides a more precise detection method for the subcellular localization of CB1 receptors in the brain. Herein, we describe a single pre-embedding immunogold method for electron microscopy based on the use of specific CB1 receptor antibodies and silver-intensified 1.4 nm gold-labeled Fab' fragments, and a combined pre-embedding immunogold and immunoperoxidase method that employs biotinylated secondary antibodies and avidin-biotin-peroxidase complex for the simultaneous localization of CB1 receptors and protein markers of specific brain cells or synapses (e.g., GFAP, GLAST, IBA-1, PSD-95, gephyrin). In addition, a post-embedding immunogold method is also described and compared to the pre-embedding labeling procedure. These methods provide a relatively easy and useful approach for revealing the subcellular localization of low amounts of CB1 receptors in glutamatergic synapses, astrocytes, neuronal and astrocytic mitochondria in the brain.
www.bio-protocol.org/e3145 Inc., Yaphank, NY, USA; 1 ml/well) in 1% BSA/TBS with 0.004% saponin on a shaker for 3 h at RT.
6. Wash three times in 1% BSA/TBS (10 min each). Keep the tissue in 1% BSA/TBS on a shaker overnight at 4 °C.
7. Post-fix with 1% glutaraldehyde prepared in TBS (1 ml/well) for 10 min at RT.
8. Wash three times in double distilled water (10 min each).
9. Transfer sections to glass test tubes.
10. Intensify gold particles with the HQ Silver kit (Nanoprobes Inc., Yaphank, NY, USA; 1 ml/tube) in the dark for 12 min.
11. Wash three times in double distilled water (1 min each).
12. Wash three times in 0.1 M PB (pH 7.4) (10 min each).
13. Transfer sections to glass vials (15 ml, 3 x 5 cm).
14. Osmicate (1% osmium tetroxide in 0.1 M PB, pH 7.4; 1 ml/vial) in the dark for 20 min.
15. Wash three times in 0.1 M PB (pH 7.4) (10 min each).
16. Dehydrate in graded ethanols (50%, 70%, 96%; 5 min/each) followed by three times in 100% ethanol (5 min each) (1 ml/vial). GABAergic terminal (ter, yellow) adjacent to a dendrite (den, purple). CB1 receptor particle is localized to a presynaptic glutamatergic terminal (ter, pink) associated with a spine (sp, purple).
Mitochondria (m, red) exhibit CB1 receptor immunolabeling in both glutamatergic (ter, pink) and GABAergic (ter, yellow) presynaptic terminals (CA1 stratum radiatum, adult mouse hippocampus). B. CB1 receptor labeling (arrows) at a presynaptic GABAergic terminal (ter, yellow), glutamatergic terminals (ter, purple) and in one astrocyte branch (white arrowhead; as, of presynaptic CB1 receptors (ter; 18 nm-diameter gold particles) and postsynaptic mGluR2/3 (den, sp; 10 nm-diameter gold particles) at inhibitory (ter, yellow) and excitatory (ter, pink) synapses in the mouse dentate molecular layer. Scale bars= 500 nm.
Data analysis
A. Semi-quantification of CB1 receptor immunolabeling in pre-embedding method
With the aim of maximizing the standard conditions, the pre-embedding immunogold method is applied simultaneously to all the sections obtained from the animals under study (at least n = 3).
Three replicated experiments are done for each animal.
Immunogold-labeled resin-embedded vibratome sections are first visualized under the light microscope in order to select portions of the region of interest (i.e., CA1 hippocampus, dentate molecular layer, prelimbic cortex or piriform cortex) with reproducible CB1 receptor immunolabeling.
Then, semi-thin sections from resin-embedded tissue are cut and the first five ultra-thin sections are receptor density (particles/µm membrane) in positive terminals is calculated as explained before. In addition, with the aim of determining the precise sub-synaptic distribution of mGluR2/3 (or any other receptor) in postsynaptic elements relative to the presynaptic release sites, the distribution of gold particles frequency is measured. Also, the sub-synaptic CB1 receptor distribution in presynaptic boutons can be determined. In this situation, the synaptic or peri/extrasynaptic localization of the gold particle is defined with respect to its allocation in 60 nm-wide segments obtained from the edge of both the postsynaptic density and the presynaptic active zone (localization at the edge = 0).
Statistical analysis is performed as described in the pre-embedding method section. Filter the solution to remove any undissolved material
